SUBSTITUIERTE 11-PHENYL-DIBENZAZEPIN-VERBINDUNGEN, DIE NÜTZLICH SIND ZUR BEHANDLUNG ODER VORBEUGUNG VON DURCH ABNORMALE ZELLPROLIFERATION GEKENNZEICHNETEN KRANKHEITEN

The present invention provides substituted 11-phenyl-dibenzazepine compounds which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of dise...

Full description

Saved in:
Bibliographic Details
Main Authors HALPERIN, JOSE, BRUGNARA, CARLO, HAIDAR, REEM M, KELLEHER, EUGENE W, CLIFFORD, JOHN J, LOMBARDY, RICHARD JOHN, MOUSSA, ADEL M, BELLOTT, EMILE M, FLUCKIGER, RUDOLF, SUN, MINGHUA, ZELDIN, MICHAEL H, SACHDEVA, YESH P, TAFT, HEATHER N, GAO, YING-DUO
Format Patent
LanguageGerman
Published 06.03.2008
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides substituted 11-phenyl-dibenzazepine compounds which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.
Bibliography:Application Number: DE19986038002T